Is STRATA Skin Sciences Inc (SSKN) overvalued? · rev $33.6M
STRATA Skin Sciences Inc (SSKN) is a medical devices company listed on NASDAQ.
This page asks whether STRATA Skin Sciences Inc (SSKN) looks expensive on cached numbers — not a short thesis.
Latest reported SSKN revenue for 2024-12-31 was $33.6M. Net income was -$10.1M. Revenue was up 0.6% from 2023-12-31 to 2024-12-31. SSKN currently screens at market cap $877.3K.
SSKN currently screens at market cap $877.3K. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SSKN 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SSKN stock page for the full model, not this heading.
Not investment advice.